Skip to content

Drug interactions

Nateglinide + Nilotinib

Severity: Moderate

Nateglinide and Nilotinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nilotinib inhibits CYP2C9 and CYP3A4 in vitro and could raise nateglinide exposure. This may increase glucose lowering and the risk of hypoglycemia, although clinical data are limited. Nilotinib also commonly affects glucose levels.

What this interaction means in plain words

Nateglinide and Nilotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Nateglinide belongs to Endocrine; Nilotinib belongs to Oncology.

Evidence level: Low

Why it happens

Nilotinib inhibits CYP2C9 and CYP3A4, potentially reducing nateglinide metabolism.

What to do

Monitor blood glucose after starting nilotinib and reduce the nateglinide dose if hypoglycemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nateglinide and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nateglinide with Nilotinib?

MediHelp rates the interaction as moderate. Nateglinide and Nilotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nilotinib inhibits CYP2C9 and CYP3A4 in vitro and could raise nateglinide exposure. This may increase glucose lowering and the risk of hypoglycemia, although clinical data are limited. Nilotinib also commonly affects glucose levels.

How serious is the interaction between Nateglinide and Nilotinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose after starting nilotinib and reduce the nateglinide dose if hypoglycemia occurs.

What other medicines interact with Nateglinide?

MediHelp also lists interactions of Nateglinide with, for example, Albiglutide, Alogliptin-metformin, Alogliptin-pioglitazone. The full list is on the Nateglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in